FDA has approved Bellafill for the treatment of skin condition scars
U.S. Food and Drug Administration (FDA) has approved the dermal filler, Bellafill- polymethylmethacrylate (PMMA) collagen filler - for the treatment of skin condition scars. Bellafill represents a big clinical advancement because the solely filler on the market approved for this disfiguring skin condition. skin condition is that the commonest skin condition within the U.S., poignant 40-50 million people1 and up to ninety fifth of individuals with skin condition could endure to suffer from scarring. Bellafill was studied extensively before its office approval and established to be safe and effective for the correction of moderate to severe, atrophic, expansive facial skin condition scars on the cheek in patients over the age of twenty one years.